Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026)
Zai Lab's (ZLAB) quarterly Other Accumulated Expenses came in at $47.0 million in Q1 2026, up 27.71% year-on-year from $36.8 million in Q1 2025, and down 26.18% quarter-over-quarter from $63.7 million in Q4 2025.
Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Other Accumulated Expenses across 11 years of filings, most recently posting $47.0 million for Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $47.0 million, up 27.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.0 million (up 27.71% YoY), and the FY2025 annual result was $63.7 million, up 8.45% from the prior year.
- Other Accumulated Expenses came in at $47.0 million for Q1 2026 at Zai Lab, down from $63.7 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $83.0 million in Q4 2023 to a low of $36.8 million in Q1 2025.
- The 5-year median for Other Accumulated Expenses is $51.5 million (2025), against an average of $54.5 million.
- Across the five-year window, Other Accumulated Expenses decreased 29.23% in 2024 and increased 27.71% in 2026, its largest moves.
- Zai Lab's Other Accumulated Expenses stood at $66.8 million in 2022, then grew by 24.18% to $83.0 million in 2023, then slipped by 29.23% to $58.7 million in 2024, then increased by 8.45% to $63.7 million in 2025, then decreased by 26.18% to $47.0 million in 2026.
- The last three Other Accumulated Expenses figures came in at $47.0 million (Q1 2026), $63.7 million (Q4 2025), and $51.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.01 Mn |
| Dec 31, 2025 | 63.68 Mn |
| Sep 30, 2025 | 51.54 Mn |
| Jun 30, 2025 | 44.05 Mn |
| Mar 31, 2025 | 36.81 Mn |
| Dec 31, 2024 | 58.72 Mn |
| Sep 30, 2024 | 46.08 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 48.18 Mn |
| Dec 31, 2023 | 82.97 Mn |
| Sep 30, 2023 | 62.99 Mn |
| Jun 30, 2023 | 59.02 Mn |
| Mar 31, 2023 | 50.88 Mn |
| Dec 31, 2022 | 66.82 Mn |
| Sep 30, 2022 | 58.46 Mn |
| Jun 30, 2022 | 53.61 Mn |
| Mar 31, 2022 | 49.96 Mn |
| Dec 31, 2021 | 60.81 Mn |
| Sep 30, 2021 | 54.29 Mn |
| Jun 30, 2021 | 61.93 Mn |